IHC Kits and Reagents Citations
OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.
Search citations by gene symbols or target names
Here are some of the recent papers making use of OriGene products by fellow researchers.
Target | Research Paper | Journal | Product | SKU |
---|---|---|---|---|
The Binding of PD-L1 and Akt Facilitates Glioma Cell Invasion Upon Starvation via Akt/Autophagy/F-Actin Signaling | Front Oncol., 2019 Dec | IHC Kits and Reagents | D13-6 | |
A 3D epithelial–mesenchymal co-culture model of human bronchial tissue recapitulates multiple features of airway tissue remodeling by TGF-ß1 treatment | Respir Res, 2019 Nov | IHC Kits and Reagents | D39-6 | |
Triple Therapy with MerTK and PD1 Inhibition plus Radiotherapy Promotes Abscopal Antitumor Immune Responses | Clin Cancer Res, 2019 Sep | IHC Kits and Reagents | D39-6 | |
CARMA3/NF-?B signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate | World J Gastroenterol., 2019 Sep | IHC Kits and Reagents | D39-6 | |
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes | EBioMedicine, 2019 Jul | IHC Kits and Reagents | D39-6 | |
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes | EBioMedicine, 2019 Jul | IHC Kits and Reagents | D37-6 | |
Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma | EBioMedicine., 2019 Jul | IHC Kits and Reagents | D41-6 | |
Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma | EBioMedicine., 2019 Jul | IHC Kits and Reagents | D39-6 | |
Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma | EBioMedicine., 2019 Jul | IHC Kits and Reagents | D37-6 | |
Interleukin (IL)-13 and IL-17A contribute to neo-osteogenesis in chronic rhinosinusitis by inducing RUNX2 | EBioMedicine, 2019 Jul | IHC Kits and Reagents | D41-6 | |
Interleukin (IL)-13 and IL-17A contribute to neo-osteogenesis in chronic rhinosinusitis by inducing RUNX2 | EBioMedicine, 2019 Jul | IHC Kits and Reagents | D39-6 | |
Interleukin (IL)-13 and IL-17A contribute to neo-osteogenesis in chronic rhinosinusitis by inducing RUNX2 | EBioMedicine, 2019 Jul | IHC Kits and Reagents | D37-6 | |
Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients | Cells, 2019 Jun | IHC Kits and Reagents | DS204A-6 | |
LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p | Cancer Med., 2019 Jun | IHC Kits and Reagents | D13-6 | |
Revisiting the Clinical Scoring System for the Prognosis of Chronic Rhinosinusitis with Nasal Polyps | Yonsei Med J., 2019 May | IHC Kits and Reagents | D41-6 | |
Revisiting the Clinical Scoring System for the Prognosis of Chronic Rhinosinusitis with Nasal Polyps | Yonsei Med J., 2019 May | IHC Kits and Reagents | D39-6 | |
Revisiting the Clinical Scoring System for the Prognosis of Chronic Rhinosinusitis with Nasal Polyps | Yonsei Med J., 2019 May | IHC Kits and Reagents | D37-6 | |
Integration of metabolomics and expression of enolase-phosphatase 1 links to hepatocellular carcinoma progression | Theranostics, 2019 May | IHC Kits and Reagents | D11-6 | |
Integration of metabolomics and expression of enolase-phosphatase 1 links to hepatocellular carcinoma progression | Theranostics, 2019 May | IHC Kits and Reagents | D12-6 | |
Integration of metabolomics and expression of enolase-phosphatase 1 links to hepatocellular carcinoma progression | Theranostics, 2019 May | IHC Kits and Reagents | D13-6 | |
Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress | Redox Biol, 2019 Apr | IHC Kits and Reagents | D11-6 | |
Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress | Redox Biol, 2019 Apr | IHC Kits and Reagents | D12-6 | |
Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress | Redox Biol, 2019 Apr | IHC Kits and Reagents | D13-6 | |
Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients | Cancer Cell Int., 2019 Apr | IHC Kits and Reagents | D43-6 | |
LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer | Invest New Drugs, 2019 Feb | IHC Kits and Reagents | D11-6 | |
LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer | Invest New Drugs, 2019 Feb | IHC Kits and Reagents | D12-6 | |
LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer | Invest New Drugs, 2019 Feb | IHC Kits and Reagents | D13-6 | |
Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice | Front Immunol., 2019 Jan | IHC Kits and Reagents | D46-6 | |
Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice | Front Immunol., 2019 Jan | IHC Kits and Reagents | D39-6 | |
Detection of circulating tumor cells in patients with pituitary tumors | BMC Cancer. | IHC Kits and Reagents | D41-6 | |
Detection of circulating tumor cells in patients with pituitary tumors | BMC Cancer. | IHC Kits and Reagents | D39-6 | |
Detection of circulating tumor cells in patients with pituitary tumors | BMC Cancer. | IHC Kits and Reagents | D37-6 | |
BCAT1 promotes proliferation of endometrial cancer cells through reprogrammed BCAA metabolism | Int J Clin Exp Pathol., 2018 Dec | IHC Kits and Reagents | D39-6 | |
Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma | Medicine (Baltimore), 2018 Aug | IHC Kits and Reagents | D11-6 | |
Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma | Medicine (Baltimore), 2018 Aug | IHC Kits and Reagents | D12-6 | |
Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma | Medicine (Baltimore), 2018 Aug | IHC Kits and Reagents | D13-6 | |
H3K4me3 and Wdr82 are associated with tumor progression and a favorable prognosis in human colorectal cancer | Oncol Lett, 2018 Jun | IHC Kits and Reagents | D13-6 | |
Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer | BMC Cancer, 2018 May | IHC Kits and Reagents | D37-6 | |
Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer | BMC Cancer, 2018 May | IHC Kits and Reagents | D39-6 | |
Cell-centred meta-analysis reveals baseline predictors of anti-TNFa non-response in biopsy and blood of patients with IBD | Gut, 2018 Apr | IHC Kits and Reagents | D11-6 | |
Cell-centred meta-analysis reveals baseline predictors of anti-TNFa non-response in biopsy and blood of patients with IBD | Gut, 2018 Apr | IHC Kits and Reagents | D12-6 | |
Cell-centred meta-analysis reveals baseline predictors of anti-TNFa non-response in biopsy and blood of patients with IBD | Gut, 2018 Apr | IHC Kits and Reagents | D13-6 | |
High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma | , 2018 Mar | IHC Kits and Reagents | D41-6 | |
High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma | , 2018 Mar | IHC Kits and Reagents | D39-6 | |
High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma | , 2018 Mar | IHC Kits and Reagents | D37-6 | |
Effects of splanchnic vasoconstrictors on liver regeneration and survival after 90% rat hepatectomy | Ann Surg Treat Res, 2018 Feb | IHC Kits and Reagents | D39-6 | |
Interleukin-10 promotes primary rat hepatic stellate cell senescence by upregulating the expression levels of p53 and p21 | Mol Med Rep., 2018 Feb | IHC Kits and Reagents | D41-6 | |
Interleukin-10 promotes primary rat hepatic stellate cell senescence by upregulating the expression levels of p53 and p21 | Mol Med Rep., 2018 Feb | IHC Kits and Reagents | D39-6 | |
Interleukin-10 promotes primary rat hepatic stellate cell senescence by upregulating the expression levels of p53 and p21 | Mol Med Rep., 2018 Feb | IHC Kits and Reagents | D37-6 | |
Interleukin-10 promotes primary rat hepatic stellate cell senescence by upregulating the expression levels of p53 and p21 | Mol Med Rep., 2018 Feb | IHC Kits and Reagents | D46-6 |